Vicora, Inc. reports Form D for $2.5 million private offering

Vicora, Inc., a Delaware corporation based in Buffalo, New York, filed a Form D notice with the Securities and Exchange Commission disclosing an exempt securities offering. The filing is listed as a new notice with a first sale date of April 1, 2026.¹

The offering involves equity securities.¹ Vicora claimed the Rule 506(b) exemption under federal securities law.¹ According to the filing, this transaction is not tied to a merger, acquisition, or similar corporate combination.

The total offering amount was set at $2,500,000, with $2,300,000 already sold and $200,000 remaining to be sold.¹ The minimum investment accepted from any outside investor was $25,000.¹ The company reported 59 investors had already put money into the offering.¹

No sales commissions or finders' fees were reported.¹ The filing also listed $0 in proceeds allocated to payments for executive officers, directors, or promoters named in the disclosure.¹

Vicora declined to disclose its revenue range or aggregate net asset value in the filing.¹ The company identified its industry as biotechnology within the health care sector.¹

The filing named four related persons. Matthew Colpoys and Richard Ducharme are listed as both executive officers and directors, Shawn Patterson as an executive officer, and William Maggio as a director.¹ Matthew Colpoys, identified as Chief Financial Officer, signed the notice on September 18, 2026.¹